BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8018918)

  • 21. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
    Feuring-Buske M; Frankel AE; Alexander RL; Gerhard B; Hogge DE
    Cancer Res; 2002 Mar; 62(6):1730-6. PubMed ID: 11912147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth pattern and clinical correlation of subcutaneously inoculated human primary acute leukemias in severe combined immunodeficiency mice.
    Yan Y; Salomon O; McGuirk J; Dennig D; Fernandez J; Jagiello C; Nguyen H; Collins N; Steinherz P; O'Reilly RJ
    Blood; 1996 Oct; 88(8):3137-46. PubMed ID: 8874214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variable cytotoxicity of diphtheria toxin 388-granulocyte-macrophage colony-stimulating factor fusion protein for acute myelogenous leukemia stem cells.
    Feuring-Buske M; Frankel A; Gerhard B; Hogge D
    Exp Hematol; 2000 Dec; 28(12):1390-400. PubMed ID: 11146161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary blasts from infants with acute lymphoblastic leukemia cause overt leukemia in SCID mice.
    Uckun FM; Waurzyniak BJ; Sensel MG; Chelstrom L; Crotty ML; Gaynon PS; Reaman GH
    Leuk Lymphoma; 1998 Jul; 30(3-4):269-77. PubMed ID: 9713959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. JTE-607, a multiple cytokine production inhibitor, ameliorates disease in a SCID mouse xenograft acute myeloid leukemia model.
    Uesato N; Fukui K; Maruhashi J; Tojo A; Tajima N
    Exp Hematol; 2006 Oct; 34(10):1385-92. PubMed ID: 16982331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct in vivo engraftment and growth patterns of t(1;19)+/E2A-PBX1+ and t(9;22)+/BCR-ABL+ human leukemia cells in SCID mice.
    Waurzyniak BJ; Heerema N; Sensel MG; Gaynon PS; Kraft P; Sather HN; Chelstrom L; Reaman GH; Uckun FM
    Leuk Lymphoma; 1998 Dec; 32(1-2):77-87. PubMed ID: 10037003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of T-lymphocytic leukemia-initiating stem cells residing in a small subset of patients with acute myeloid leukemic disease.
    Risueño RM; Campbell CJ; Dingwall S; Levadoux-Martin M; Leber B; Xenocostas A; Bhatia M
    Blood; 2011 Jun; 117(26):7112-20. PubMed ID: 21562049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric acute myelogenous leukemia cells express IL-6 receptors and are sensitive to a recombinant IL6-Pseudomonas exotoxin.
    Boayue KB; Gu L; Yeager AM; Kreitman RJ; Findley HW
    Leukemia; 1998 Feb; 12(2):182-91. PubMed ID: 9519780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human acute myeloid leukemia blast-derived exosomes in patient-derived xenograft mice mediate immune suppression.
    Hong CS; Danet-Desnoyers G; Shan X; Sharma P; Whiteside TL; Boyiadzis M
    Exp Hematol; 2019 Aug; 76():60-66.e2. PubMed ID: 31369790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemia.
    Her Z; Yong KSM; Paramasivam K; Tan WWS; Chan XY; Tan SY; Liu M; Fan Y; Linn YC; Hui KM; Surana U; Chen Q
    J Hematol Oncol; 2017 Oct; 10(1):162. PubMed ID: 28985760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term leukemia-initiating capacity of a CD34-subpopulation of acute myeloid leukemia.
    Terpstra W; Prins A; Ploemacher RE; Wognum BW; Wagemaker G; Löwenberg B; Wielenga JJ
    Blood; 1996 Mar; 87(6):2187-94. PubMed ID: 8630378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth of human T-cell lineage acute leukemia in severe combined immunodeficiency (SCID) mice and non-obese diabetic SCID mice.
    Steele JP; Clutterbuck RD; Powles RL; Mitchell PL; Horton C; Morilla R; Catovsky D; Millar JL
    Blood; 1997 Sep; 90(5):2015-9. PubMed ID: 9292537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retroviral marking of acute myelogenous leukemia progenitors that initiate long-term culture and growth in immunodeficient mice.
    Ailles LE; Humphries RK; Thomas TE; Hogge DE
    Exp Hematol; 1999 Nov; 27(11):1609-20. PubMed ID: 10560908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth of primary human acute lymphoblastic and myeloblastic leukemia in SCID mice.
    De Lord C; Clutterbuck R; Powles R; Morilla R; Hanby A; Titley J; Min T; Millar J
    Leuk Lymphoma; 1994 Dec; 16(1-2):157-65. PubMed ID: 7696922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience.
    Bagheri K; Alimoghadam K; Pourfathollah AA; Hassan ZM; Hajati J; Moazzeni SM
    Pathol Oncol Res; 2009 Jun; 15(2):257-67. PubMed ID: 18807213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice.
    Namikawa R; Ueda R; Kyoizumi S
    Blood; 1993 Oct; 82(8):2526-36. PubMed ID: 8104540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target.
    Mussai F; Egan S; Higginbotham-Jones J; Perry T; Beggs A; Odintsova E; Loke J; Pratt G; U KP; Lo A; Ng M; Kearns P; Cheng P; De Santo C
    Blood; 2015 Apr; 125(15):2386-96. PubMed ID: 25710880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Chemo-enzymatically Linked Bispecific Antibody Retargets T Cells to a Sialylated Epitope on CD43 in Acute Myeloid Leukemia.
    Bartels L; de Jong G; Gillissen MA; Yasuda E; Kattler V; Bru C; Fatmawati C; van Hal-van Veen SE; Cercel MG; Moiset G; Bakker AQ; van Helden PM; Villaudy J; Hazenberg MD; Spits H; Wagner K
    Cancer Res; 2019 Jul; 79(13):3372-3382. PubMed ID: 31064847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
    Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
    Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase.
    Wang JC; Lapidot T; Cashman JD; Doedens M; Addy L; Sutherland DR; Nayar R; Laraya P; Minden M; Keating A; Eaves AC; Eaves CJ; Dick JE
    Blood; 1998 Apr; 91(7):2406-14. PubMed ID: 9516140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.